Open Access

A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro

  • Authors:
    • Yongcheng Wang
    • Jie Yao
    • Haoye Meng
    • Zhiguo Yu
    • Zhigang Wang
    • Xueling Yuan
    • Hong Chen
    • Aiyuan Wang
  • View Affiliations

  • Published online on: December 1, 2014     https://doi.org/10.3892/mmr.2014.3024
  • Pages: 2534-2540
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long non‑coding RNAs (lncRNAs) have recently been identified as novel modulators of malignant tumors. However, the function of lncRNAs in cancer stem cells (CSCs) remains to be elucidated. The present study aimed to investigate the regulating role of a novel lncRNA, hypoxia‑inducible factor‑2α (HIF‑2α) promoter upstream transcript (HIF2PUT), in osteosarcoma stem cells. The expression levels of HIF2PUT were assessed by quantitative polymerase chain reaction in 17 osteosarcoma tissue specimens, and the correlation between the expression of HIF2PUT and its host transcript‑HIF‑2α was determined. In functional experiments, HIF2PUT expression was knocked down by small interfering RNAs, or overexpressed by transfection with pcDNA‑HIF2PUT, in order to evaluate the effects of HIF2PUT on cell proliferation, migration, expression rate of osteosarcoma stem cell marker CD133, and stem sphere‑forming ability in MG63 cells. HIF2PUT expression levels were positively correlated with HIF‑2α in osteosarcoma tissues. Overexpression of HIF2PUT markedly inhibited cell proliferation and migration, decreased the percentage of CD133 expressing cells, and impaired the osteosarcoma stem sphere‑forming ability of the MG63 cells. Whereas, knockdown of HIF2PUT expression had the opposite effect. Furthermore, altering the expression of HIF2PUT resulted in a concomitant change to HIF‑2α mRNA expression. These results indicate that the lncRNA HIF2PUT may be a novel regulatory factor of osteosarcoma stem cells, which may exert its function partly by controlling HIF‑2α expression. Further studies regarding HIF2PUT may provide a novel therapeutic target of osteosarcoma in the future.

References

1 

Stiller CA: International patterns of cancer incidence in adolescents. Cancer Treat Rev. 33:631–645. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC and Gebhardt MC: Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res. 429:286–291. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Harting MT, Blakely ML, Jaffe N, et al: Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg. 41:194–199. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Merlos-Suárez A, Barriga FM, Jung P, et al: The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 8:511–524. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Takahashi S, Kamiyama T, Tomaru U, et al: Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients. Oncol Rep. 24:1201–1212. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Ailles LE and Weissman IL: Cancer stem cells in solid tumors. Curr Opin Biotechnol. 18:460–466. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Huarte M and Rinn JL: Large non-coding RNAs: missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Tsai MC, Spitale RC and Chang HY: Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Guttman M, Donaghey J, Carey BW, et al: lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Preker P, Nielsen J, Kammler S, et al: RNA exosome depletion reveals transcription upstream of active human promoters. Science. 322:1851–1854. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Jacquier A: The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs. Nat Rev Genet. 10:833–844. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Preker P, Almvig K, Christensen MS, et al: PROMoter uPstream Transcripts share characteristics with mRNAs and are produced upstream of all three major types of mammalian promoters. Nucleic Acids Res. 39:7179–7193. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Taft RJ, Kaplan CD, Simons C and Mattick JS: Evolution, biogenesis and function of promoter-associated RNAs. Cell Cycle. 8:2332–2338. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Ijichi N, Ikeda K, Fujita M, et al: EPAS1, a dexamethasone-inducible gene in osteoblasts, inhibits osteoblastic differentiation. Open Bone J. 1:28–37. 2009. View Article : Google Scholar

16 

Li Z, Bao S, Wu Q, et al: Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 15:501–513. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Gordan JD, Bertout JA, Hu CJ, Diehl JA and Simon MC: HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 11:335–347. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Covello KL, Kehler J, Yu H, et al: HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20:557–570. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Yang X, Song JH, Cheng YL, et al: Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 63:881–890. 2014. View Article : Google Scholar

20 

Siclari VA and Qin L: Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res. 5:782010. View Article : Google Scholar : PubMed/NCBI

21 

Tirino V, Desiderio V, d’Aquino R, et al: Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One. 3:e34692008. View Article : Google Scholar

22 

Williams GT, Mourtada-Maarabouni M and Farzaneh F: A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes. Biochem Soc Trans. 39:482–486. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Knowles HJ, Schaefer KL, Dirksen U and Athanasou NA: Hypoxia and hypoglycaemia in Ewing’s sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor. BMC Cancer. 10:3722010. View Article : Google Scholar

24 

Acker T, Diez-Juan A, Aragones J, et al: Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell. 8:131–141. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Yu L and Hales CA: Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice. BMC Cancer. 11:3312011. View Article : Google Scholar : PubMed/NCBI

26 

Biswas S, Charlesworth PJ, Turner GD, et al: CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. Carcinogenesis. 33:1717–1725. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2015
Volume 11 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Y., Yao, J., Meng, H., Yu, Z., Wang, Z., Yuan, X. ... Wang, A. (2015). A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro. Molecular Medicine Reports, 11, 2534-2540. https://doi.org/10.3892/mmr.2014.3024
MLA
Wang, Y., Yao, J., Meng, H., Yu, Z., Wang, Z., Yuan, X., Chen, H., Wang, A."A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro". Molecular Medicine Reports 11.4 (2015): 2534-2540.
Chicago
Wang, Y., Yao, J., Meng, H., Yu, Z., Wang, Z., Yuan, X., Chen, H., Wang, A."A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro". Molecular Medicine Reports 11, no. 4 (2015): 2534-2540. https://doi.org/10.3892/mmr.2014.3024